Expression and Clinical Significance of Hsa-miR-9 in Colon Carcinoma

Shaoxin GONG,Qiang ZHAO,Yingzhi ZHUANG,Rongfang HE,Shuai YANG,Qingbiao ZENG,Hui DING,Xiaoli ZHANG,Jian SU

DOI: https://doi.org/10.3969/j.issn.1000-8179.2011.12.008

2011-01-01

Chinese Journal of Clinical Oncology

Abstract:Objective:To explore the expression and clinical significance of hsa-miR-9 in colon carcinoma.Methods:Tissue samples were collected from 62 cases of colon carcinoma from June 2007 to December 2009,with paracancerous tissues as the normal controls.Hybridization in situ and real-time quantitative polymerase chain reaction were used to detect the hsa-miR-9 expression in those specimens.The relationship between hsa-miR-9 expression and the clinicopathologic parameters was determined.Results:Hybridization in situ showed that the positive expression rate of the hsa-miR-9 was 88.71% in colon carcinoma and 17.74% in the paracancerous tissues;the difference was statistically significant (P<0.01).The real-time quantitative PCR showed that the expression of hsa-miR-9 was (3.77±0.42) times higher in colon carcinoma than in normal tissue;the differences were statistically significant (P< 0.01).This indicates that the upregulation of hsa-miR-9 expression is associated with advanced clinical stages.It was 4.23±0.18 and 2.24±0.31 times higher than paracancerous tissues,respectively,for stage Ⅲ/Ⅳ and stage Ⅰ/Ⅱ colon carcinoma;the difference was statistically significant in different groups (P<0.05).The expression of hsa-miR-9 was 3.12 times higher with lymph node metastasis than without lymph node metastasis in colon carcinoma;the difference was statistically significant (P<0.01).The expression of hsa-miR-9 was not associated with degree of differentiation;the difference was not statistically significant (P>0.05).Conclusion: Hsa-miR-9 is related to the occurrence and metastasis of colon carcinoma,and it could be a predictive biomarker in the treatment and prognosis of colon carcinoma.